RIDDELL, R.H. The precarcinomatous phase of ulcerative colitis.
Curr. Topics Pathol.
,
Berlin, v. 63, p. 179-219, 1976.
RIDDELL, R.H.; GOLDMAN, H.; RANSOHOFF, D.F.; APPELMAN, H.D.; FENOGLIO, C.M.;
HAGGITT, R.C.; AHREN, C.; CORREA, P.; HAMILTON, S.R.; MORSON, B.C.; SOMMERS,
S.C.; YARDLEY, J.H. Displasia in inflammatory bowel disease: standardized classification
with provisional clinical applications.
Human Pathology
, Philadelphia, v. 14, n. 11, p. 931-
968, 1983.
RIEGLER, G.; BOSSA, F.; CASERTA, L..; PERA, A.; TONELLI, F.; STURNIOLO, G.C.;
OLIVA, L.; CONTESSINI, A.E.; POGGIOLI, G. Colorectal cancer and high grade dysplasia
complicating ulcerative colitis in Italy: a retrospective co-operative IG-IBD study.
Dig. Liver
Dis.
, Roma, v. 35, p. 628-634, 2003.
ROSE, S. Inflammatory bowel disease. In: _____ (Ed).
Gastrointestinal and
hepatobiliary
pathophysiology
. Madison Conn: Fence Creek Publishing, 1998. p. 245-257.
RUBIN, C.E.; HAGGITT, R.C.; BURMER, G.C.; BRENTNALL, T.A.; STEVENS, A.C.;
LEVINE, D.S.; DEAN, P.J.; KIMMEY, M.; PERERA, D.R.; RABINOVITCH, P.S. DNA
aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.
Gastroenterology
, Philadelphia, v. 103, p. 1611-20, 1992.
SARTOR, R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel
diseases.
Gastroenterology
, Philadelphia, v. 92, Suppl 12, p. 5S-11S, 1997.
SHIRASAWA, S.; URABE, K.; YANAGAWA, Y.; TOSHITANI, K.; IWAMA, T.; SASAZUKI, T.
p53 gene mutations in colorectal tumors from patients with familial polyposis coli.
Cancer
Res.
, Baltimore, v. 51, p. 2874-2878, 1991.
SILVESTRINI, R.; BENINI, E.; DAIDONE, M.G.; VENERONI, S.; BORACCHI, P.;
CAPPELLETTI, V.; DI FRONZO, G.; VERONESI, U. p53 as an independent prognostic
marker in lymphnode-negative breast cancer patients.
J. Natl. Cancer Inst.
, Bethesda, v.85,
p. 965-970, 1993.
SPENCER, M.
Fundamentals of light microscopy
. Cambridge: University Press, 1982.
STENSON, W. Inflammatory bowel disease. In: YAMADA et al. (Ed.).
Textbook of
gastroenterology
. Philadelphia: J.B. Lippincott, 1995. v. 1, p. 1754-1757.
TALBOT, I.C.; PRICE A. B.
Biopsy pathology in colorectal disease
.
London: Chapman
and Hall, 1987, p. 117-145.
TANAKA, M.; RIDDELL, R.H.; SAITO, H.; SOMA, Y.; HIDAKA, H.; KUDO, H. Morphologic
criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease
from others forms of colitis and of Crohn’s disease from ulcerative
colitis.
Scandinavian
Journal of Gastroenterology
, Oslo, v. 34, p. 55-67, 1999.
TSIANOS, E.V. Risk of câncer in inflammatory bowel disease (IBD).
European Journal of
Internal Medicine
, Amsterdam, v. 11, p. 75-78, 2000.
TYTGAT, G.N.J.; DHIR, V.; GOPINATH, N. Endoscopic appearance of dysplasia and câncer
in inflammatory bowel disease.
Eur. J. Cancer
, Oxford, v. 31A, n. 7/8, p. 1174-1177, 1995.